Enhance-d
PrivateLast Round
Grant
Mar 10, 2025
Total Funding Raised
$984,000
Company Overview
Enhance-d operates in Healthcare & Life Sciences and is based in Bern. Its latest recorded funding round was a Grant round in March 2025.
Enhance-d is a digital health company that provides a platform for diabetes self-management by integrating data from continuous glucose monitors, wearables, and lifestyle apps to provide personalized exercise and health insights.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, Patient Engagement, Health IoT
Business Model
B2C
Customer Profile
Subscription SaaS, Freemium
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Enhance-d Comparables
Compare Enhance-d with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GLAICE | 81% | |
| Fitscript | 79% | |
| SmartStart Health | 73% |
For institutional investors. Book with your work email.
Enhance-d Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 10, 2025 | ||||
| Pre Seed | Jan 25, 2023 | ||||
| Grant | Dec 22, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Enhance-d Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Plug and Play Tech Center | Pre Seed |
| Diabetes Center Berne | Grant |
| Qatar Development Bank | Grant |
| Innosuisse | Grant |
| StartUp Health | Pre Seed |
| Swiss ICT Investor Club | Pre Seed |
| Venture Kick | Pre Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 6, 2026
Monthly visitors increased 37% MoM.
- Mar 10, 2025
$5K grant received from Qatar Development Bank
For institutional investors. Book with your work email.
Enhance-d Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Enhance-d's valuation, stock price, and market status.
Is Enhance-d a public or private company?
Enhance-d is a private company.
What is the current stock price of Enhance-d?
Enhance-d is a private company, so its shares have no public market price. Caplight tracks Enhance-d's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Enhance-d worth (valuation)?
Valuation information for Enhance-d is not publicly available.
Can I buy Enhance-d stock?
Enhance-d shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Enhance-d's last funding round?
Enhance-d's most recent funding round was Grant on March 10, 2025.
Who are the main investors in Enhance-d?
Key investors in Enhance-d include Plug and Play Tech Center, Diabetes Center Berne, Qatar Development Bank, Innosuisse, StartUp Health.
Will Enhance-d IPO soon?
No public IPO plans have been announced for Enhance-d.
How can I track Enhance-d secondary market activity?
Caplight tracks bids, offers, and trades in Enhance-d's shares on secondary markets.